Synthetic Biology-Based Therapeutics Summit
December 7 - 9, 2021 - MA USHanson Wade
info@hansonwade.com
Phone:+442031418700
Investigate Foundational Technologies, Applications, and Manufacturing Strategies to Create Advanced, Controllable Drugs at the Only Technical Meeting to Explore the Therapeutic Applications of Synthetic Biology. This year, the synthetic biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules and controllable therapeutics grows exponentially. The therapeutic potential of novel synthetic units is huge, but challenges remain in demonstrating proof-of-concept, developing assays, functional characterization, manufacturing scale-up, and identifying therapeutic applications for commercial development. With an agenda curated by leaders in synthetic biology-based therapies at Synlogic, Merck, Bayer, Senti Bio, MIT and GSK, the Synthetic Biology-Based Therapeutics Summit will provide strategic insights to deploy synthetic biology as a tool for discovery, through to therapeutic applications. Explore innovations in circuit design and implementation, harnessing the power of computation and AI to better design functioning circuits and uncover novel components which elicit therapeutic benefit. Tackle manufacturing challenges to scale up synthetic biology-based therapeutics with gold-standard quality control and characterization.